| |
| |
|
| Insider
Information: |
Hyde Joseph R III |
| Relationship: |
Director |
| City: |
Memphis |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
4,411,298 |
|
|
Indirect Shares
|
2,672,247 |
|
|
| Direct
Value |
$235,016,621 |
|
|
|
Indirect Value
|
$6,500,627 |
|
|
| Total
Shares |
7,083,545 |
|
|
| Total
Value |
$241,517,248 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Fedex Corp |
FDX |
Director |
2009-04-29 |
132,000 |
2008-11-03 |
0 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
Director, 10% Owner |
2019-01-02 |
4,207,368 |
2019-01-02 |
2,670,247 |
Premium* |
|
|
Autozone Inc |
AZO |
Director |
2018-01-01 |
71,930 |
2018-01-01 |
2,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
178 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2006-07-01 |
4 |
A |
$9.10 |
$5,000 |
D/D |
549 |
6,943,011 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2006-10-01 |
4 |
A |
$9.24 |
$5,000 |
D/D |
541 |
6,943,552 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2006-11-01 |
4 |
GA |
$0.00 |
$0 |
I/I |
78,965 |
215,021 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2006-11-01 |
4 |
GD |
$0.00 |
$0 |
I/I |
78,965 |
0 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2006-12-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(290,752) |
341 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2006-12-19 |
4/A |
A |
$0.00 |
$0 |
I/I |
649 |
649 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2006-12-19 |
4 |
A |
$0.00 |
$0 |
D/D |
77,880 |
6,050,347 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2007-01-01 |
4 |
A |
$17.84 |
$5,000 |
D/D |
280 |
6,050,627 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2007-04-01 |
4 |
A |
$20.40 |
$5,000 |
D/D |
245 |
6,050,872 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2007-07-01 |
4 |
A |
$16.19 |
$5,000 |
D/D |
309 |
6,140,028 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2007-09-30 |
4 |
A |
$16.28 |
$2,250 |
D/D |
138 |
6,140,166 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2007-10-01 |
4 |
A |
$16.28 |
$5,000 |
D/D |
307 |
6,140,474 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2007-11-21 |
4 |
GA |
$0.00 |
$0 |
I/I |
585,908 |
410,323 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2007-11-21 |
4 |
GD |
$0.00 |
$0 |
I/I |
585,908 |
0 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2007-12-05 |
4 |
S |
$13.90 |
$13,761 |
I/I |
(990) |
0 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2007-12-05 |
4 |
B |
$13.90 |
$13,761 |
D/D |
990 |
7,113,488 |
3.92 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2007-12-31 |
4 |
A |
$14.35 |
$2,250 |
D/D |
157 |
7,113,644 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2008-01-01 |
4 |
A |
$14.35 |
$5,000 |
D/D |
348 |
7,113,993 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2008-03-11 |
4 |
A |
$13.27 |
$517,335 |
I/I |
38,716 |
715,716 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2008-03-31 |
4 |
A |
$16.08 |
$3,000 |
D/D |
187 |
7,114,179 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2008-04-01 |
4 |
A |
$16.08 |
$5,000 |
D/D |
311 |
7,114,490 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2008-06-30 |
4 |
A |
$14.35 |
$2,250 |
D/D |
157 |
7,215,873 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2008-07-02 |
4 |
A |
$14.35 |
$5,000 |
D/D |
348 |
7,216,221 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2008-09-30 |
4 |
A |
$19.02 |
$2,250 |
D/D |
118 |
7,216,340 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2008-10-01 |
4 |
A |
$19.02 |
$5,000 |
D/D |
263 |
7,216,603 |
0 |
- |
|
178 Records found
|
|
Page 4 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
